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Abstract 23 
As a neonicotinoid pesticide, imidacloprid is widely used to control sucking 24 
insects on agricultural planting and fleas on domestic animals. However, the extent to 25 
which imidacloprid exposure has an influence on cardiogensis in early embryogenesis 26 
is still poorly understood. In vertebrates, the heart is the first organ to be formed. In 27 
this study to address whether or not imidacloprid exposure affects early heart 28 
development, the early chick embryo has been used as an experimental model because 29 
of the accessibility of chick embryo at its early developmental stage. The results 30 
demonstrate that exposure of the early chick embryo to imidacloprid caused 31 
malformation of heart tube. Furthermore，the data reveal that down-regulation of 32 
GATA4, Nkx2.5 and BMP4 and up-regulation of Wnt3a led to aberrant 33 
cardiomyocyte differentiation. In addition, imidacloprid exposure interfered with 34 
basement membrane (BM) breakdown, E-cadherin/Laminin expression and mesoderm 35 
formation during the epithelial-mesenchymal transition (EMT) in gastrula chick 36 
embryos. Finally, the DiI-labeled cell migration trajectory indicated that imidacloprid 37 
restricted the cell migration of cardiac progenitors to primary heart field in gastrula 38 
chick embryos. A similar observation was also obtained from the cell migration assay 39 
of scratch wounds in vitro. Additionally, imidacloprid exposure negatively affected 40 
the cytoskeleton structure and expression of corresponding adhesion molecules. Taken 41 
together, these results reveal that the improper EMT, cardiac progenitor migration and 42 
differentiation are responsible for imidacloprid exposure-induced malformation of 43 
heart tube during chick embryo development. 44 
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Introduction 49 
Organogenesis requires the precise layout of multiple cell types into a specific 50 
three-dimensional architecture that is essential for normal organ formation. During 51 
embryonic organ development, an obligatory process is tissue fusion, such as that of 52 
the optic cup, palate, heart, neural tube, eyelids and body wall 1, 2. Tissue fusion 53 
appears to occur in numerous organs. Our previous study demonstrated that the 54 
deficiency of specific transcription factors and signaling molecules could exhibit the 55 
fusion defects in many organs, for instance, in neural tube defects 3 and cardiac bifida 56 
4. As a model of organogenesis, cardiogenesis involves a series of morphogenetic 57 
steps. In vertebrates, the heart develops from three distinct pools of cardiac 58 
progenitors: the cardiac precursor in splanchnic mesoderm (primary and secondary 59 
heart field), cardiac neural crest and the pro-epicardium. From the perspective of 60 
morphological alteration, it is chronologically composed of primary heart tube fusion, 61 
cardiac looping and accretion, cardiac septation and coronary vasculogenesis 5. The 62 
primary heart field gives rise to the major structures of the heart, including the atrias 63 
and ventricles, while the secondary heart field contributes to the cardiac outflow tracts 64 
6. Myocardial progenitors undergo Epithelial-Mesenchymal Transition (EMT), 65 
proliferate, differentiation and migration into the primary heart field in the process of 66 
heart tube formation. EMT is a morphogenetic transition process in which cells lose 67 
their epithelial characteristics and gain mesenchymal properties underlying the 68 
alterations of adheren junction (AJs), tight junction (TJs) and gap junction (GJs) 7, 8. 69 
In the formation of primary heart fields, the precardiac cells initially migrate out of 70 
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the anterior primitive streak at the gastrula stage and then move symmetrically into 71 
crescent location 9-11. Cell migration, proliferation and differentiation are guided by its 72 
micro-environment 12.  73 
The morphogenesis of chick cardiac looping involves four phases: pre-looping 74 
phase (HH8-9); C-shaped bend (HH9+-13); S-shaped heart loop (HH14-16) and 75 
primitive outflow tract formation (about 4.5 days). Within days 6-14, expansion and 76 
growth of the ventricular wall benefit principally from cardiomyocyte proliferation in 77 
the compact myocardium. At day 14.0, cardiac neural crest cells (CNCs) give rise to 78 
the adventitia of the large veins and the coronary arteries. In this context, any 79 
disruption to cardiac precursor cell migration and differentiation during cardiogenesis 80 
may result in congenital heart malformations. 81 
Heart development is a complex process that is tightly regulated through 82 
spatio-temporal gene expression and cell-cell interaction. In previous studies of heart 83 
tube assembly in the chick embryo, we have reported that fibroblast growth factor 84 
(FGF) signaling, through an endoderm-derived signal, is required for regulating 85 
pro-cardiac mesoderm cell migration 10, 13. Additionally, bone morphogenetic protein 86 
2 (BMP2) is released from the anterior endoderm and Wnt antagonists are essential 87 
for precardiac mesoderm cells to differentiate into mature cardiomyocytes during 88 
cardiomyogenesis 14-16. Furthermore, transcription factors Nkx-2.5, GATA4, 89 
myocardin and TBX5 have crucial roles in dictating morphogenesis and 90 
differentiation of the heart 16, 17. Vascular endothelial growth factor (VEGF) also plays 91 
a vital role in the angiogenic expansion of the early network 18. 92 
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The neonicotinoid pesticide, imidacloprid, 93 
1-((6-Chloro-3-pyridinyl)methyl)-N-nitroimidazolidinimine, has been extensively 94 
used to control sucking insects, termites, soil insects on crops 19 and fleas on domestic 95 
animals 20, 21. Various products containing this chemical, including liquids, granules, 96 
dusts and packages, have been sold in the US since 1994. In the EU, use of 97 
imidacloprid was restricted for 2 years in 2013 because research showed a link 98 
between imidacloprid and bee death (EASAC 2015, Ecosystem services, agriculture 99 
and neonicotinoids). As a systemic insecticide, imidacloprid products are usually 100 
sprayed on soil and leaves, and then spread to the plant's stems, leaves, fruit and 101 
flowers 22, 23. Imidacloprid can then penetrate into the nervous system of sucking 102 
insects and combine selectively with nicotinic acetylcholine receptors (nAChR), 103 
producing toxic effects 24. When insects consume plants treated with imidacloprid 104 
products, their nervous systems are damaged leading to death. Due to steric conditions 105 
at the nAChR, imidacloprid has much lower toxicity to mammals. However, humans 106 
can be exposed to imidacloprid products via skin/eye contact or through consumption 107 
or inhalation when handling the pesticide or an animal recently exposed to 108 
imidacloprid. The toxicity of imidacloprid in human adults is due to disruption of 109 
nervous system signal transduction 25. Once humans are exposed, imidacloprid 110 
products can cross the lining of the intestine and be transported to the whole body 111 
through circulation of the blood. However, little is known about its potential toxic 112 
effects on early embryo development apart from a few reports on human health such 113 
as reproductive ability. Currently, increasing attention is being paid to the toxic effects 114 
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of pesticides on embryo development, including cardiovascular system. Unfortunately, 115 
as yet there is no direct evidence of toxicological effects on cardiogenesis or 116 
corresponding mechanisms. In this study, a chick embryo model 26 has been used to 117 
investigate whether or not imidacloprid could affect cardiogenesis and, if so, to 118 
elucidate the underlying cellular and molecular mechanism. 119 
 120 
Materials and methods 121 
Chick manipulations 122 
Fertilized leghorn eggs were acquired from the Avian Farm of South China 123 
Agriculture University (Guangzhou, China). Two approaches were employed to carry 124 
out the imidacloprid exposure in this study. The imidacloprid powder was dissolved in 125 
dimethyl sulfoxide (DMSO), 0.1% DMSO was used as control to observe the 126 
potential effect of the solvent. 127 
For imidacloprid exposure at the early embryonic stage, Hamburger-Hamilton 128 
(HH) stage 0 chick embryos from fertilized eggs were incubated with either 0.1% 129 
DMSO (control) or 500 µM imidacloprid 27 in early chick (EC) culture medium in a 130 
humidified incubator (Yiheng Instruments, Shanghai, China) at 38°C and 70% 131 
humidity until the chick embryos developed to the HH10 stage. Alternatively, 500 µM 132 
imidacloprid was directly applied to one side of the gastrula-stage embryos, with the 133 
other side being exposed to 0.1% DMSO as a control.  134 
For imidacloprid exposure at a later embryonic stage, HH4 chick embryos were 135 
exposed to either 0.1% DMSO (control) or 500 µM imidacloprid through injection 136 
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into windowed eggs in vivo and then further incubated for 4.5 days and 14 days. The 137 
experiments were performed in triplicate with 20 eggs assigned to each group, and 138 
surviving embryos were harvested for further assessment.  139 
In situ hybridization 140 
Whole-mount in situ hybridization of chick embryos was performed according to 141 
a standard in situ hybridization protocol 28 . Briefly, digoxigenin-labeled probes were 142 
synthesized for VMHC 29, GATA5 30, BMP2 and NKX2.5 (supplied by Dr. Thomas M. 143 
Schultheiss). The whole-mount stained embryos were photographed and then frozen 144 
sections prepared on a cryostat microtome (LeicaCM1900) at a thickness of 15–20 145 
mm. 146 
Immunofluorescent staining 147 
Chick embryos were harvested at the end of the experiment and fixed overnight 148 
in 4% paraformaldehyde at 4°C. Whole-mount embryos were immunofluorescently 149 
stained using MF20 (1:500, DSHB, USA), E-cadherin (1:50, BD Transduction 150 
Laboratories, USA), Laminin (1:100, DSHB, USA) antibodies. Briefly, the fixed 151 
embryos were incubated with these primary antibodies at 4°C overnight on a rocker. 152 
Following extensive washing, the embryos were incubated with the appropriate 153 
anti-mouse IgG conjugated to Alexa Fluor 488 or anti-rabbit IgG conjugated to Alexa 154 
Fluor 555 (1:1000, Invitrogen, USA), overnight at 4°C on a rocker. All embryos were 155 
finally counterstained with DAPI (1:1000, Invitrogen, USA) at room temperature for 156 
1 hour. 157 
RNA isolation and semiquantitative RT-PCR 158 
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Total RNA was isolated from HH4, HH8 chick embryos using a Trizol kit 159 
(Invitrogen, USA) according to the manufacturer’s instructions. First-strand cDNA 160 
was synthesized to a final volume of 25μl using SuperScript RIII first-strand 161 
(Invitrogen, USA). Following reverse transcription, PCR amplification of the cDNA 162 
was performed as described previously. The primers used for RT-PCR are provided in 163 
the Figure S3. The PCR reactions were performed on a Bio-Rad S1000TM Thermal 164 
cycler (Bio-Rad, USA). The final reaction volume was 50 μl composed of 1 μl of 165 
first-strand cDNA, 25 μM forward primer, 25 μM reverse primer, 10 μl 166 
PrimeSTARTM Buffer (Mg2+ plus), 4μl dNTPs Mixture (TaKaRa, Japan), 0.5 μl 167 
PrimeSTARTM HS DNA Polymerase (2.5U/μl TaKaRa, Japan) and RNase-free water. 168 
The cDNA was amplified for 30 cycles. One round of amplification was performed at 169 
94°C for 30 s, 30 s at 58°C, and 30 s at 72°C. The PCR products (20 μl) were resolved 170 
using 1% agarose gels (Biowest, Spain) in 1× TAE buffer (0.04 M Trisacetate and 171 
0.001 MEDTA) and 10,000x GeneGreen Nucleic Acid Dye (Tiangen, China) solution. 172 
The resolved products were visualized using a transilluminator (Syngene, UK) and 173 
photographs captured using a computer-assisted gel documentation system (Syngene). 174 
The housekeeping gene GAPDH was run in parallel to confirm that equal amounts of 175 
RNA were used in each reaction. The ratio between intensity of the fluorescently 176 
stained bands corresponding to genes and GAPDH was calculated to quantify the 177 
level of the transcripts for those genes mRNAs. The RT-PCR result was representative 178 
of three independent experiments. 179 
Cell trace with DiI 180 
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Carbocyanine dye 1, 1V-dioctadecyl-3, 3, 3V, 3V-tetramethylindocarbocyanine 181 
perchlorate (DiI, Molecular Probes, Inc.) was used to label small groups of primitive 182 
streak cells. A 2.5% stock solution of DiI was diluted in ethanol, 1:10 in 0.3 M 183 
sucrose, and injected into the anterior primitive streak of HH3 chick embryo by air 184 
pressure through a micropipette, which was pulled from a 1 mm glass capillary in a 185 
vertical micropipette puller (WD-2, Chengdu Instrument Company). In general, each 186 
labeled tissue in the anterior primitive streak contained approximately 10–30 cells. 187 
Cell lines and culture 188 
The H9c2 rat cardiac myoblast cell line was obtained from ATCC (American 189 
Type Culture Collection, CLR-1446, USA). The cells were cultured in a humidified 190 
incubator with 5% CO2 at 37°C in six-well plates (1×106 cells/ml) containing DMEM 191 
(Gibco, Gaithersburg, MD, USA), supplemented with 10% fetal bovine serum (Gibco, 192 
Gaithersburg, MD, USA), and exposed to imidacloprid (500μM); 0.1% DMSO was 193 
used as a control. The cells were photographed using an inverted fluorescence 194 
microscope (Nikon, Tokyo, Japan) with NIS-Elements F3.2 software. After 12 hours 195 
incubation, immunofluorescent staining against phalloidin (F-actin, 1:1000, 196 
Invitrogen, Waltham, MA, USA) and anti-Myh7 (1:100, Proteintech, USA) was 197 
performed on the incubated H9c2 cells. A minimum of 5 images were assayed per 198 
treatment group. DAPI (1:1000, Invitrogen, USA) was used as counterstain. 199 
Migration assay 200 
H9c2 cells were seeded in 6-well plates with DMEM (10% FBS) medium. At 201 
confluency, a wound was induced by scratching the monolayer with a 10-μl pipette tip. 202 
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The cells were then washed 3 times with sterile PBS. H9c2 cells were incubated in 203 
serum-free DMEM medium with 500uM or 0.1% DMSO under 5% CO2 conditions. 204 
Images were acquired at 12h and 24h post-scratching. At least 3 wells were analyzed 205 
in each treatment group and the images were taken using an inverted microscope 206 
(Nikon Eclipse Ti-U, Japan). 207 
Western blot  208 
Chick embryos (HH4 and HH7) were collected and lysed with CytoBuster™ 209 
Protein Extraction Reagent (#71009, Novagen). The total protein concentration was 210 
established using a BCA quantification kit (BCA01, DingGuo BioTECH, CHN). 211 
Samples containing equal amounts of protein were resolved by SDS-PAGE and then 212 
transferred to PVDF membranes (Bio-Rad). The membranes were blocked with 5% 213 
Difco™ skim milk (BD) and then incubated with primary and secondary antibodies. 214 
The antibodies used were TBX5 ， GATA4 and GATA6 (Abcam USA), 215 
HRP-conjugated anti-mouse IgG and anti-rabbit IgG (Cell Signaling Technology, 216 
USA). All primary and secondary antibodies used were diluted to 1:1000 and 1:2000 217 
in 5% skim milk, respectively. The protein bands of interest were visualized using an 218 
ECL kit (#34079, Thermo Fischer Scientific Inc.) and GeneGnome5 (Syngene). The 219 
staining intensity of the bands was determined and analyzed using Quantity One 220 
software (Bio-Rad).  221 
Photography 222 
Following immunofluorescent staining or in situ hybridization, the whole-mount 223 
embryos were photographed using a stereo-fluorescent microscope (Olympus MVX10) 224 
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and associated Olympus software package Image-Pro Plus 7.0. The embryos were 225 
sectioned into 14 µm-thick slices using a cryostat microtome (Leica CM1900) and the 226 
sections were then photographed with an epi-fluorescent microscope (Olympus LX51, 227 
Leica DM 4000B) and CN4000 FISH Olympus software package. 228 
Data analysis 229 
The thickness of ventricular wall and trabecular muscle and the distance of 230 
wound closure in wound healing experiments as well as the lengths of the long and 231 
short axes were all quantified with Image-Pro Plus 6.0. The cell trace with DiI 232 
experiments, Dil+ cells were manually counted with Image-Pro Plus 6.0. Statistical 233 
analyses for all the experimental data was performed using a SPSS 13.0 statistical 234 
package program for Window. The data were presented as mean ± SD. Statistical 235 
significance were determined using paired T-test, independent samples T-test or 236 
one-way analysis of variance (ANOVA). *p<0.05, **p<0.01 and ***p<0.001 indicate 237 
statistically significance between control and drug-treated groups. P < 0.05 was 238 
considered to be significant.  239 
 240 
Results 241 
Imidacloprid exposure increases cardiac malformation during chick cardiogenesis 242 
The heart is the first functional organ in the developing embryo. There are three 243 
crucial phases in the development of heart formation: 2-, 4.5- and 14-day (Fig. 1A). 244 
To investigate the effects of excess imidacloprid exposure on heart tube formation in 245 
chick embryos, we cultured the embryos as shown in Figure S1. In the first place, we 246 
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found that 35% (n = 28/80), 42.5% (n = 34/80) and 50% (n = 40/80) of 500μM 247 
imidacloprid-treated chick embryos had died after 2, 4.5 and 14 days incubation, 248 
respectively. Corresponding mortalities were only 5% (n = 3/60), 6.67% (n = 4/60) 249 
and 8.33% (n = 5/60) in the 0.1% DMSO-treated chick embryos (Fig. 1B). Our results 250 
showed that the growth of imidacloprid-treated embryos is slightly faster than 0.1% 251 
DMSO-treated ones at 21h and, conversely, slightly delayed at 48h. (21h: DMSO = 252 
1345 ± 74.43μm, imidacloprid = 1629 ± 82.45μm, P < 0.05; 48h: DMSO = 4183 ± 253 
45.57μm, imidacloprid = 3866 ± 56.58μm, P < 0.001; n = 40 for each groups; Figs. 254 
1C-C5, D). 255 
The average number of somites in imidacloprid-treated group at 48h was about 256 
10 pairs compared to 12 pairs in 0.1% DMSO-treated group (DMSO = 12.43 ± 0.17, 257 
imidacloprid = 10.03 ± 0.15, n = 40 for each groups, P < 0.05; Fig. 1E). Next, E4.5 258 
imidacloprid-treated whole embryos weights were obviously lower than 0.1% 259 
DMSO-treated ones (DMSO = 0.26 ± 0.03g, n = 10, imidacloprid = 0.19 ± 0.01g, n = 260 
34, P < 0.01; Fig. 1F). H&E staining revealed that the thicknesses of the ventricular 261 
walls (DMSO = 47.52 ± 0.95μm, n = 10, imidacloprid = 28.85 ± 0.72μm, n = 14, P < 262 
0.001) and the trabecular muscles were both reduced in imidacloprid-treated group 263 
compared with 0.1% DMSO-treated controls (DMSO = 25.27 ± 0.56μm, n = 10, 264 
imidacloprid = 12.57 ± 0.31μm, n = 14, P < 0.001; Figs. 1G, G1-G2, H, H1-H2; I, J). 265 
Additionally, the size and weight of imidacloprid-treated hearts were smaller and 266 
lighter than those of 14-day 0.1% DMSO-treated embryos (DMSO = 0.08 ± 0.01g, n 267 
= 10; imidacloprid = 0.07 ± 0.01g, n = 16, P < 0.05; Figs. 1K, L, M). The weight of 268 
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whole embryo showed a similar tendency (DMSO = 7.60 ± 0.31g, n = 10, 269 
imidacloprid = 6.03 ± 0.29g. n = 16, P < 0.01; Fig. 1N). Transverse sections (Figs. 270 
1K1, L1) and histograms established that the right ventricular wall (RV) was 271 
dramatically thicker (DMSO = 409.10 ± 24.73μm, n = 10, imidacloprid = 598.20 ± 272 
36.10μm. n = 16, P < 0.001; Fig. 1O) whilst there was no significant difference in the 273 
left ventricular wall (LV) and interventricular septum (ISV). 274 
Some atypical C-looping heart tube was evident when imidacloprid-treated 275 
embryos reached HH10. According to the phenotype features, we divided them into 276 
four classifications: normal (Figs. 2A, B), mild (Figs. 2A1, B1), intermediate (Figs. 277 
2A2, B2) and severe (Figs. 2A3, B3), and all were stained with MF20 antibody and 278 
ventricular myosin heavy chain (VMHC) probe, respectively. In the 0.1% 279 
DMSO-treated embryonic heart, the heart tubes are fully C-looped (normal = 100%, n 280 
= 80/80), while abnormal morphological looping of heart tube occurred in the 281 
imidacloprid-treated groups (normal = 13.6%, n = 8/59, mild = 39%, n = 23/59, 282 
intermediate = 28.8%, n = 17/59, severe = 18.6%, n = 11/59; Fig. 2C). At stage HH10, 283 
the C-shape loop of the heart tube has formed in control embryos (Fig. 2D) as 284 
indicated by MF20 immunofluorescent-staining (Fig. 2E). The single cavity of the 285 
heart tube was also evident in corresponding transverse sections for these 0.1% 286 
DMSO-treated embryos (Figs. 2F, F1-F3). In contrast, some heart tubes of the HH10 287 
imidacloprid-treated chick embryos presented in cardiac bifida (Fig. 2G), as shown in 288 
the MF20 immunofluorescently-stained heart tubes (Fig. 2H) and corresponding 289 
transverse section of the heart tubes. The two cavities were found in the transverse 290 
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sections of the heart tubes (Figs. 2I, I1-I3).  291 
Imidacloprid treatment represses cardiomyocyte differentiation 292 
Figure 3A reveals the principal signaling pathways (Wnt, BMP&FGF and VEGF) 293 
involved in the regulation of cardiomyocyte differentiation at cardiac crescent stages 294 
(HH7-8). To explore whether imidacloprid exposure affects these crucial gene 295 
expressions of cardiomyocyte formation, we firstly exposed imidacloprid to one side 296 
of the embryos, using the other side as control. This approach has been previously 297 
described in detail 31, and its advantage is in avoiding experimental artifacts due to the 298 
different velocities of embryo development. In situ hybridization results (Fig. 3B) 299 
showed that both GATA5 and Nkx2.5 expression were down-regulated on the 300 
imidacloprid-treated side, while VMHC and BMP2 expression was maintained. The 301 
results of RT-PCR showed that imidacloprid exposure increased Wnt3a expression; 302 
dramatically inhibited GATA4, TBX5, VEGFR2 and BMP4 expression, but did not 303 
affect BMP2, Fgf8 and VMHC expression (Fig. 3C). The comparisons of gene 304 
expressions are shown in Figure S.2A. The results of westren-blot showed that the 305 
imidacloprid exposure inhibited GATA4, GATA6 and TBX5 expression at protein 306 
level (Fig. 3D-E). 307 
Imidacloprid exposure interfered with EMT at gastrula chick embryos 308 
Cardiac progenitor cells derived from lateral plate mesoderm cells, which were 309 
undergo EMT (Fig. 4A). During EMT, E-Cadherin down-regulation and N-cadherin 310 
up-regulation are considered to be indispensable 32. Here, E-Cadherin in 311 
DMSO-treated embryos was mainly expressed in the apical side of epiblast (Figs. 4B, 312 
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B1-B1’). In contrast, expression of E-Cadherin in imidacloprid-induced embryos 313 
extended to epiblast, mesoderm and hypoblast (Figs. 4C, C1-C1’). RT-PCR showed 314 
that imidacloprid treatment reduced expression of N-cadherin and increased that of 315 
E-Cadherin.  316 
During chick gastrulation, the earliest sign of EMT is the breakdown of BM at the 317 
midline 33-35. Compared to 0.1% DMSO-treated embryos (Figs. 4D, D1-D1’), 318 
imidacloprid treatment shortened the midline distance (DMSO = 241.80 ± 13.99μm, n 319 
= 10, imidacloprid = 170.50 ±7.60μm, n = 10, P < 0.01; Figs. 4E, E1-E1’, F), 320 
implying that EMT was delayed. RT-PCR data (Fig. 4G) showed no significant 321 
difference between the expression of RhoA between DMSO and imidacloprid groups. 322 
Imidacloprid treatment reduced the expression of P120, β-catenin, CX43 and 323 
claudin12; increased the expression of Vinculin, Par3 and occluding, but had no effect 324 
on expression of AJs and TJs, including Wnt3a, Claudin-1, ZO-1 and α-actin. As a 325 
result, it is concluded that imidacloprid treatment induced delayed EMT during 326 
cardiogenesis in gastrula chick embryo. The comparisons of gene expressions are 327 
shown in Figure S. 2B and C. The results of westren-blot showed that the expression 328 
imidacloprid exposure down regulated N-cadherin, but up regulated E-cadherin at 329 
protein level (Figs. 4H-I). 330 
Imidacloprid inhibited the migration of cardiac progenitor cells 331 
Cardiac progenitor cells are the resources of the heart tube and migrate bilaterally 332 
in the lateral plate mesoderm to eventully form the cardiac crescent 9, 10. To follow the 333 
migration trajectory of cardiac progenitor cells, DiI dye was injected into anterior 334 
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primitive streaks in HH3 chick embryos as shown in Figs. 5A, 5B. The embryos were 335 
then exposed and cultured on either 0.1% DMSO (control) on both sides (Fig. 5A) or 336 
with imidacloprid on one side (Fig. 5B). The photographs were taken after 9-hour and 337 
20-hour incubations. The results showed that the Dil+ mesoderm cells in the control 338 
group migrated symmetrically at bilateral sides of embryos (n = 18, P > 0.05; Figs. 339 
5C-E, C1-E1, F), while many fewer Dil+ mesoderm cells were observed after 9- and 340 
20-hour incubations at the side of imidacloprid-treatment compared to the control 341 
(DMSO = 91.00 ± 1.38, imidacloprid = 43.38 ± 1.45, n = 18, P < 0.001; Figs. 5G-I, 342 
G1-I1, J-K).. This difference in Dil+ cardiac progenitor cell migration clearly suggests 343 
that imidacloprid exposure restrained the cell migration of cardiac precursors towards 344 
the site of heart tube formation. 345 
Imidacloprid exposure suppressed the migration, polarization, and protrusion 346 
formation of cardiac cells in vitro. 347 
To examine the behavior of treated cells, we used H9c2 cells cultured in vitro in 348 
presence of imidacloprid. The scratch-wound assay showed that imidacloprid 349 
exposure inhibited H9c2 cells migration, as reflected in the extent of “wound” closure 350 
after 24h incubation from the 0.1% DMSO and imidacloprid-treated groups 351 
respectively (12h: DMSO = 41.93 ± 1.06%, imidacloprid = 32.54 ± 2.66%, P < 0.05; 352 
24h: DMSO = 61.47 ± 0.92%, imidacloprid = 46.81 ± 2.07%, P < 0.001, n = 8 for 353 
each group; Figs. 6A, B, B1-B2, C, C1-C2, D). Actin and Myh7 are primary 354 
cytoskeletal components and are involved in the formation of cell filopodia, 355 
lamellipodia and protrusions during cell migration 36. F-actin and Myh7 fluorescent 356 
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microscopy demonstrated that compared to 0.1% DMSO exposure (Figs. 6E-F, I) 357 
imidacloprid exposure (Figs. 6G-H, J) caused a loss of cell polarization. To quantify 358 
this effect, the ratios of long to short axes of cells exposed to either DMSO or 359 
imidacloprid were calculated.  360 
Elongation of cells exposed to imidacloprid was significantly less than that of 361 
0.1% DMSO-treated control cells (DMSO = 3.13 ± 0.24μm, n = 25, imidacloprid = 362 
2.31 ± 0.11μm, n = 25, P < 0.01; Fig. 6K). More cell protrusions occurred in the 363 
majority of cells exposed to 0.1% DMSO compared to those treated with imidacloprid 364 
(DMSO = 85.69 ± 3.19, imidacloprid = 59.79 ± 2.89, n = 10 for each group, P < 0.01; 365 
Fig. 6L). In addition, the fluorescence intensities of Myh7 were determined (DMSO = 366 
188.50 ± 0.94, n = 25, imidacloprid = 136.60 ± 3.10, n = 32, P < 0.001; Fig.6M). 367 
RT-PCR data (Fig.6N) revealed that imidacloprid treatment reduced the expressions 368 
of Vinculin, Par3, ZO-1, CX-43, Claudin-1 and ɑ-actin, but increased the expression 369 
of P120. The other tight junction gene (Claudin-12) was not affected. The 370 
comparisons of gene expressions are shown in Figure S.2D. Furthermore, we also 371 
detected the behavior of imidacloprid-treated chicken cardiac muscle cells 37. The 372 
results confirmed that imidacloprid exposure could suppress the migration, 373 
polarization, and protrusion formation of cardiac cells in vitro (Figure S.4). 374 
 375 
Discussion 376 
 The toxicity of imidacloprid varies greatly across species. As a neurotoxic  377 
insecticide, it has been used globally to control sucking insects in agriculture and 378 
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animal husbandry 19. Similarly, monocrotophos, an organophosphate insecticide, also 379 
has been found to greatly affect the development of zebrafish in a 380 
concentration-dependent manner 38 It has been reported that concentrations of 381 
imidacloprid in the environment was 320 μg/L near Noordwijkerhout, Nethelands, 382 
exceeding European toxicity directives, while one fifth of water samples taken in 383 
California were above the United States Environmental Protection Agency’s level for 384 
invertebrates (35 μg/L for acute toxicity and 1.05 μg/L for chronic toxicity) 39. 385 
Accumulation of this pesticide on plants and animals will inevitably be transferred to 386 
humans through close contacts and food contamination. A study on the biological 387 
safety of imidacloprid products is therefore particularly important 27, 40. In a previous 388 
study, we conducted a concentration gradient to select the proper concentration. In our 389 
previous study, we conducted a concentration gradient to select the proper 390 
concentration. We found that mortality and ratio of malformations were both 391 
increased with the increase of the concentration 41. The concentration of imidacloprid 392 
(500 µM) in this study was similar to that reported for earlier literature reports 27. We 393 
considered that, for an acute toxicity experiment, the acceptable range should be less 394 
than 1000 times the environmental concentrations, and the concentration we selected 395 
here, 500 μM (127.8 mg/L), was within this range. α7nAChR has been reported to be 396 
increased during cardiac hypertrophy in the rat 42. Our previous study also found that 397 
AChR and AChE were presented in early chick embryos. We detected these 398 
expressions with acetylcholinesterase and acetylcholine receptors by RT-PCR. This 399 
work shows that expressions of both acetylcholinesterase and acetylcholine receptors 400 
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were inhibited by treatment with imidacloprid 43. Pregnant women is a kind of 401 
vulnerable groups, human embryonic development is likely to be affected by 402 
cumulative toxic effects if pregnant women are exposed over the long-term to 403 
imidacloprid. During embryogenesis, the heart is the first organ to be developed. 404 
Severe developmental defects in the heart could cause embryonic death. Hence, it is 405 
vital to determine whether or not exposure to this widely-used chemical could affect 406 
development.  407 
The chick embryo was selected to systemically investigate the potential toxic effect 408 
of imidacloprid exposure on early heart tube formation in this study. Chick embryos 409 
develop to HH10 for about 2days. Ventricular segment firstly bulge ventrally and then 410 
flips to the right side. In this way, the heart fuses and a primitive C-shaped heart tube 411 
is formed 16. At 4.5 days, the cardiac looping process is completed 44. At 14 days, the 412 
expansion and growth of the ventricular wall has ended and a mature heart is 413 
produced (Fig. 1A). Our results show that imidacloprid exposure significantly 414 
retarded the growth of chick embryos (Fig. 1) and increased the incidence of different 415 
degrees of cardiac malformations (Fig. 2). MF20, the marker of myosin II heavy chain 416 
in muscles, was exploited to outline the morphology of heart tubes, and is clearly 417 
expressed in the myocardium of single and complete heart tubes in 0.1% 418 
DMSO-treated control (Figs. 2F, F1-F3). In contrast, the unfused cavity marked by 419 
MF20 is evident in the imidacloprid-treated group (Figs. 2I, I1-I3) implying that 420 
imidacloprid exposure might result in cardia bifida. Furthermore, the development of 421 
ventricular wall and trabecular muscle in 4.5 days was delayed by the imidacloprid 422 
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treatment. In comparison to the reduction of cardiac volume and weight in 14 days, 423 
the thickness of right ventricular wall was significantly increased in compensation 424 
following imidacloprid exposure (Fig. 1O). Imidacloprid exposure-induced embryonic 425 
mortality in the first two days is much higher than in the other two phases (Fig. 1B). 426 
This finding also further confirms that the first two days is the crucial period for heart 427 
tube formation. It was this period that we addressed in this study.  428 
Morphogenesis of the heart tube during embryo development relies on a precisely 429 
coordinated expression of cardiac-associated genes. Crescent formation mainly 430 
requires several signal factors, including Wnt, BMP and Fgf signaling, which 431 
coordinately control cardiomyocyte differentiation-related genes (NKX2.5, 432 
GATA4/5/6 and T-box). . Among those signal pathways, Wnt3a/β-catenin signal is 433 
deemed to be a negative regulator, the others being positive 16. In this study, we found 434 
that imidacloprid exposure up-regulated Wnt3a expression and slightly 435 
down-regulated the expression of BMP4, with not much change being observed in the  436 
expressions of BMP2 and Fgf8. Knock-out or mutation of GATA4 and GATA5, the 437 
zinc-ﬁnger transcription factors for cardiogenesis, leads to cardia bifida in mice 45 438 
whilst over-expression of GATA5 induces ectopic Nkx2.5 expression. The GATA6 439 
promoter in both mouse and chick contains functionally important Nkx2.5 binding 440 
sites. Similarly, the murine Nkx2.5 promoter contains GATA sites that are involved in 441 
early heart field expression 46. Likewise, the unlooped heart is associated with TBX5 442 
mutation. Furthermore, VEGFR2 and its ligand VEGF are the cardiac- and endothelial 443 
marker at the cardiac crescent stage 47. It has been observed that imidacloprid 444 
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exposure could result in an obvious down-regulation of VEGFR2 (Fig. 3). From the 445 
results of western blot we also found the down regulaoted of GATA4, GATA6 and 446 
TBX5. All these results imply that imidacloprid-treated could significantly inhibit 447 
cardiomyocyte differentiation during heart tube formation. 448 
It is known that cardiac crescent cells date from myocardial precursor cells initiated 449 
at the anterior primitive streak of gastrula embryo. Using the Dil+ migration assay, we 450 
showed that the cell migration of myocardial precursor cells was suppressed by the 451 
exposure to imidacloprid (Figs. 5G-I). In comparison to the 0.1% DMSO-exposed 452 
side of embryos, the less migratory Dil+ myocardial precursor cells in the 453 
imidacloprid-exposed side demonstrate that imidacloprid exposure indeed interfered 454 
with precardiac cell migration toward the primary heart fields. However, the 455 
possibility of an influence on cell proliferation cannot be excluded.  456 
To investigate how imidacloprid affects cell migration, we employed scratch wound 457 
assay and found that exposure inhibited H9c2 cells and chicken cardiac muscle cells 458 
migration (Figs. 6B-B2, C-C2 and Fig.S4). It has been reported that cells migration 459 
properties are related to cellular cytoskeleton modulation or to relevant adherence 460 
factors 48, 49. These data show that imidacloprid exposure disturbed cell internal 461 
structure (Fig. 6G) and reduced the number of stress fibers (Fig. 6H). Moreover, cell 462 
migration also relies on cell-cell junctions, including AJs, TJs and GJs etc (Fig. 6H). 463 
Classic cadherins, including E-cadherin and N-cadherin, are crucial molecules in 464 
calcium-dependent cell adhesion and supply trans-homophilic binding to other 465 
cadherins on adjacent cells, whereas their intracellular domains firsthand interact with 466 
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p120-catenin. Vinculin, an actin-binding protein, connects intracellular actin filaments 467 
by forming a mixture of, for example, α-catenin and β-catenin 50. TJs located at the 468 
top of the lateral membranes, including the claudin family and occluding, exhibit 469 
“barrier” and “fence” functions that involve binding to intracellular ZO-1 51. GJs, such 470 
as CX43, form multiple channels that allow the passage of small molecules and 471 
electrical signals 52. All the mentioned-above cell adhesion molecules were 472 
down-regulated by imidacloprid (Fig. 6N), which suggested that this exposure 473 
certainly interfered with cell migration and cardiac crescent formation during heart 474 
tube formation. 475 
Cardiac precursor cells derive from epiblast cells after undergoing EMT. EMT not 476 
only needs to down-regulate expression of E-cadherin (required to maintain epithelial 477 
cell contact) but also requires up-regulating the expression of N-cadherin, the 478 
mesenchymal cell adhesion molecules. The Wnt/β-catenin signaling pathway plays 479 
regulatory role in the adhesion belt. Moreover, break-down of BM, marked by laminin 480 
and the alteration of others cell-cell adhesion factors (AJs, TJs, GJs), are also very 481 
important in EMT. In this research, imidacloprid treatment led to E-cadherin 482 
up-regulation and N-cadherin down-regulation at mRNA and protein levels in the 483 
gastrula chick embryos. This treatment also enhanced laminin expression but had little 484 
influence on AJs (p120, Vinculin, Par3, β-catenin) and GJs (CX43). These data 485 
indicate that imidacloprid-exposure interference with EMT is achieved through 486 
altering the relevant adhesion molecules.  487 
In summary, these studies reveal that imidacloprid exposure negatively influenced 488 
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EMT, cell migration and cell differentiation in heart tube formation. Figure 7 489 
summarises schematically how imidacloprid might cause these changes. But, at 490 
present, the mechanisms of cardiogensis are only incompletely understood.  491 
Furthermore, imidacloprid products are likely to flow into drinking water in poultry 492 
farms, which may have impact on the quantity and quality of hatching eggs.  493 
 Thus, further experiments are required to explore the precise molecular 494 
mechanism by which imidacloprid affects cardiogenesis, thereby contribute to 495 
improve poultry industry. 496 
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Figure legends  508 
Figure 1. Imidacloprid retarded development of the chick embryos and resulted in 509 
abnormal heart formation. A: The illustration shows the crucial points (2-, 4.5- and 510 
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14-day) in chick embryos heart development. B: Graph shows the mortality rate in 511 
0.1% DMSO and 500μM imidacloprid-treated chick embryos at days 2, 4.5 and 14, 512 
respectively. C-C2: Representative appearance of 0.1% DMSO-treated chick embryos 513 
for 0- (C), 21- (C1) and 48- (C2) hs. C3-C5: Representative appearance of 514 
imidacloprid-treated chick embryos for 0- (C3), 21- (C4) and 48- (C5) hs. D: Bar 515 
chart shows the length of embryos following treatment at 0-, 21-, 48h. E: Bar chart 516 
shows the pair numbers of somites at 48h. F: Bar chart shows the whole embryo 517 
weight of chick embryos in E4.5. G, G1-G2: Representative appearance of the 518 
4.5-day developing hearts in 0.1% DMSO-treated group (G), transverse section was 519 
taken at the level indicated by dotted lines in F and stained with H&E stains (G1). The 520 
high magnification images were taken from the sites indicated by boxed regions in G1 521 
(G2). The black line and boxed region in G2 marked the ventricular wall and 522 
trabecular muscle, respectively. H, H1-H2: The example shows the appearance of 523 
4.5-day developing hearts in the imidacloprid- treated group (H), transverse section 524 
was taken at the level indicated by dotted lines in H and stained with H&E stains (H1). 525 
The high magnification images were taken from the sites indicated by boxed regions 526 
in H1 (H2). The black line and boxed region in H2 dotted the ventricular wall and 527 
trabecular muscle, respectively. I: Bar chart compares the ventricular wall thickness 528 
of hearts. J: Bar chart compares the trabecular muscle layers. K: Representative 529 
appearance of the 14-day mature hearts in 0.1% DMSO-treated group. L: Example 530 
shows appearance of 14-day mature hearts in the imidacloprid- treated group. K1, L1: 531 
Transverse section was taken at the levels indicated by dashed lines in K and L. M-N: 532 
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Bar chart shows the heart weight and the whole embryo weight. O: The bar chart 533 
showing the thickness of ventricular wall in 14-day mature hearts. Abbreviations: LV, 534 
left ventricle; RV, right ventricle; IVS, interventricular septum. Scale bars = 2000 µm 535 
(C，C3); 1000 µm (C1-C2，C4-C5); 500μm (G-H); 300μm (G1-H1); 50μm (G2-H2); 536 
300μm (K-L); 1000µm (K1-L1). 537 
 538 
Figure 2. The classification of imidacloprid exposure-induced heart malformations 539 
in gastrula chick embryos. A-A3: Representative appearances of phenotypes 540 
classification of hearts in gastrulating chick embryos immunofluorescently-stained 541 
with MF20 antibody, including normal (A), mild (A1), intermediate (A2) and severe 542 
(A3), respectively. B-B3: In situ hybridization shows VMHC expression in 543 
representative appearances of phenotypes classification of hearts in gastrulating chick 544 
embryos. C: Bar chart shows the rate of heart phenotype classification (%) in 0.1% 545 
DMSO- and imidacloprid-treated group. D-E: Representative bright-field images of 546 
0.1% DMSO-treated HH10 embryo (D) and heart tube immunofluorescently-stained 547 
with MF20 antibody (E). F, F1-F3: F: Representative transverse sections at the levels 548 
indicated by dotted white line in E. DAPI staining is used as a counterstain in F1. F2 549 
is the merged image. F3 is the enlarged view of boxed region in F2. G-H: 550 
Representative bright-field images of 0.1% DMSO-treated HH10 embryo (G) and 551 
heart tube immunofluorescently-stained with MF20 antibody (H). I, I1-I3: I: 552 
Representative transverse sections at the levels indicated by dotted white line in H. 553 
DAPI staining is used as a counterstain in I1. I2 is the merged image. I3 is the 554 
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enlarged view of boxed region in I2. Scale bars = 150 µm (A1-A4, B1-B4, E, H); 500 555 
µm (D, G); 100μm (F, F1-F3, I, I1-I3). 556 
 557 
Figure 3. Imidacloprid exposure repressed the differentiation of cardiac progenitor 558 
cells. A: Overview of the signaling pathways that have been implicated into 559 
cardiomyocyte formation. B1-B4: The embryos were incubated with 0.1% DMSO 560 
(left) and imidacloprid (right) at either side until HH7 and processed for in situ 561 
hybridization for GATA5 (B1), NKX2.5 (B2), VMHC (B3), BMP2 (B4). B1’-B4’: 562 
Representative transverse sections at the levels indicated by dotted black lines in 563 
B1-B4. C: RT-PCR showing the expressions at HH7 chick embryos. D: Western-bolt 564 
showing the expressions at protein level in HH7 chick embryos. E: The bar chart 565 
showing the comparisons of gene expressions in D. Scale bars = 200 µm (B1-B4)；566 
100 µm (B1’-B4’). 567 
 568 
Figure 4. Imidacloprid exposure interfered with EMT during chick gastrulation. A: 569 
The illustration shows the EMT during chick gastrulation. B: Representative images 570 
of 0.1% DMSO-treated HH4 chick embryos immunofluorescently-stained with 571 
E-Cadherin. B1-B1’: The transverse sections at the levels indicated by dotted white 572 
line in B. The section was counterstained with DAPI (B1’). E-Cadherin is expressed 573 
on the apical side of epiblast of 0.1% DMSO-treated embryo (white arrow in B1’). C: 574 
Representative images of imidacloprid-treated HH4 chick embryos 575 
immunofluorescently-stained with E-Cadherin. C1-C1’: The transverse sections at 576 
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levels indicated by dotted white line in C. The section was counterstained with DAPI 577 
(C1’). E-Cadherin expression level was enhanced on epiblast layer, and ectopic 578 
expression in the mesoderm layer following imidacloprid treatment (white arrows in 579 
C1’). D: Representative image of 0.1% DMSO-treated HH4 chick embryos 580 
immunofluorescently-stained for laminin. D1-D1’: The transverse sections at levels 581 
indicated by dotted white line in D. The section was counterstained with DAPI (D1’). 582 
Laminin is expressed on the BM of 0.1% DMSO-treated embryo (white dotted line 583 
showing the gap in D1’). E: Representative image of imidacloprid-treated HH4 chick 584 
embryos immunofluorescently-stained for laminin. E1-E1’: The transverse sections at 585 
the levels indicated by dotted white line in E. The section was counterstained with 586 
DAPI (E1’). Laminin is expressed on the BM of imidacloprid-treated embryo (white 587 
dotted line showing the gap in E1’). F: Bar chart shows the gap distance of laminin 588 
(μm) with 0.1% DMSO- and imidacloprid-treated HH4 chick embryos. G: RT-PCR 589 
shows the expressions N-cadherinat mRNA level in the HH4 chick embryos. H: 590 
Western-bolt showing the expressions at protein level in HH4 chick embryos. I: The 591 
bar chart showing the comparisons of gene expressions in H. Scale bars = 300μm 592 
(B-E); 100μm (B1-E1, B1’-E1’). 593 
 594 
Figure 5. Imidacloprid exposure restricted cardiac progenitor cell migration. A: The 595 
pattern of DiI-labeled cardiac progenitor cell migration following 0.1% DMSO 596 
treatment on the both sides of embryos. B: The pattern of DiI-labeled cardiac 597 
progenitor cell migration following 0.1% DMSO treatment at the left side and 598 
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imidacloprid exposure at right side of embryos. C-E: Fluorescence images were taken 599 
at 0- (B), 9- (C) and 20- (D) hour. Note: both sides of embryos were exposed to 0.1% 600 
DMSO. C1-E1: The merged images of bright-field and B-D respectively. F: Bar chart 601 
shows the number of cardiac precursor cells migration based on A. G-I: Fluorescence 602 
images were taken at 0- (G), 9- (H) and 20- (I) of incubation. The left sides of 603 
embryos were exposed to 0.1% DMSO, while the right sides were exposed to 604 
imidacloprid. G1-I1: The merged images of bright-field and G-I respectively. J: Bar 605 
chart shows the number of cardiac precursor cells migration based on F. K: Bar chart 606 
shows the number of embryo incidence of symmetrical migration or asymmetric 607 
migration in 0.1% DMSO- and imidacloprid groups. Scale bars = 600μm (C-E, C1-E1, 608 
G-I, G1-I1). 609 
 610 
Figure 6. The imidacloprid exposure suppressed H9c2 cells migration, polarization 611 
and protrusion formation. A: The sketch illustrates migration of H9c2 cells as 612 
detected by the wound-healing assay. B-C: The representative images of H9c2 cells 613 
scratch test at 0-hour incubation from 0.1% DMSO-treated (B) and 614 
imidacloprid-treated (C) groups respectively. B1-C1, B2-C2: The representative 615 
images of H9c2 cells scratch test at 12-hour (B1, C1), 24-hour (B2, C2). D: The bar 616 
chart shows the percentage of wound closure (%) at 12-hour, 24-hour. E-F: 617 
Representative image of actin filaments in 0.1% DMSO -treated H9c2 cells were 618 
visualized by staining with F-actin (red), and cell nuclei were stained with DAPI 619 
(blue). White dotted lines show the long and short axes of cells. F is the enlarged view 620 
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of E. (The boxed region in F shows stress fiber assay in H9c2 cells). G-H: 621 
Representative image of actin filaments in imidacloprid-treated H9c2 cells were 622 
visualized by staining with F-actin (red), and cell nuclei were stained with DAPI 623 
(blue). White dotted lines show the long and short axes of cells. H is the enlarged 624 
view of G. (The boxed region in H shows stress fiber assay in H9c2 cells). I-J: 625 
Representative images of 0.1% DMSO and imidacloprid-treated H9c2 cells 626 
immunofluorescently-stained with Myh7, respectively. K: Bar chart showing the ratio 627 
of long axis to short axis. L: Bar chart shows cells containing stress fibers (%). M: 628 
Bar chart shows fluorescence intensity of Myh7 (AU). N: RT-PCR showing the 629 
expressions at mRNA level in HH7 chick embryos exposed either 0.1% DMSO or 630 
imidacloprid. Scale bars = 200μm (B, B1-B2, C, C1-C2); 100μm (E- J). 631 
 632 
Figure 7. Model depicting how imidacloprid exposure induced heart tube 633 
malformation during chick cardiogenesis.  634 
 635 
 636 
 637 
 638 
 639 
 640 
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